Carnosine ( DrugBank: Carnosine )
2 diseases
| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 | 
|---|---|---|
| 6 | パーキンソン病 | 1 | 
| 13 | 多発性硬化症/視神経脊髄炎 | 2 | 
6. パーキンソン病
臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment  | Date_ registration  | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor  | Secondary_ sponsor  | Recruitment_ Status  | Inclusion_ agemin  | Inclusion_ agemax  | Inclusion_ gender  | Target_ size  | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03330470 (ClinicalTrials.gov)  | January 1, 2017 | 17/10/2017 | Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease | Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease | Subjective Cognitive Impairment;Mild Cognitive Impairment;Parkinson Disease;Healthy Volunteers | Behavioral: exercise;Dietary Supplement: carnosine supplementation;Behavioral: stretching;Dietary Supplement: supplementation with placebo | Slovak Academy of Sciences | Comenius University;University Hospital Bratislava;National Cheng Kung University | Recruiting | 55 Years | 80 Years | All | 100 | N/A | Slovakia;Taiwan | 
13. 多発性硬化症/視神経脊髄炎
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
| No. | TrialID | Date_ enrollment  | Date_ registration  | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor  | Secondary_ sponsor  | Recruitment_ Status  | Inclusion_ agemin  | Inclusion_ agemax  | Inclusion_ gender  | Target_ size  | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03995810 (ClinicalTrials.gov)  | June 15, 2019 | 18/6/2019 | Oral Carnosine for Neuromuscular Performance in Multiple Sclerosis | Oral Carnosine for Neuromuscular Performance, Brain Biomarkers of Carnosine Metabolism and Health-related Quality of Life in Multiple Sclerosis | Multiple Sclerosis | Dietary Supplement: Carnosine, capsulle, 2 g/day, 8 weeks | University of Novi Sad, Faculty of Sport and Physical Education | CarnoMed | Completed | 18 Years | 65 Years | All | 3 | N/A | Serbia | 
| 2 | NCT03418376 (ClinicalTrials.gov)  | February 1, 2017 | 9/1/2018 | Carnosine Loading and Periodized Training in MS and HC | The Impact of Carnosine Loading and Rehabilitation Therapy on Exercise Capacity in Multiple Sclerosis. | Multiple Sclerosis;Exercise Therapy;Dietary Supplement | Dietary Supplement: Beta-alanine supplementation;Other: Exercise intervention | Hasselt University | NULL | Completed | 18 Years | 75 Years | All | 45 | N/A | Belgium |